Merit Medical Systems, Inc. (MMSI)
89.57
+2.41
(+2.76%)
USD |
NASDAQ |
Oct 15, 16:00
89.77
+0.20
(+0.22%)
After-Hours: 20:00
Merit Medical Systems Research and Development Expense (Quarterly) : 25.39M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.39M |
| March 31, 2026 | 22.61M |
| December 31, 2025 | 26.54M |
| September 30, 2025 | 23.97M |
| June 30, 2025 | 24.37M |
| March 31, 2025 | 22.48M |
| December 31, 2024 | 25.19M |
| September 30, 2024 | 20.53M |
| June 30, 2024 | 20.26M |
| March 31, 2024 | 21.48M |
| December 31, 2023 | 21.64M |
| September 30, 2023 | 19.65M |
| June 30, 2023 | 20.13M |
| March 31, 2023 | 21.31M |
| December 31, 2022 | 20.44M |
| September 30, 2022 | 19.22M |
| June 30, 2022 | 18.47M |
| March 31, 2022 | 17.39M |
| December 31, 2021 | 20.41M |
| September 30, 2021 | 16.97M |
| June 30, 2021 | 17.59M |
| March 31, 2021 | 16.27M |
| December 31, 2020 | 15.13M |
| September 30, 2020 | 13.51M |
| June 30, 2020 | 14.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.87M |
| December 31, 2019 | 16.25M |
| September 30, 2019 | 16.99M |
| June 30, 2019 | 16.33M |
| March 31, 2019 | 16.04M |
| December 31, 2018 | 15.37M |
| September 30, 2018 | 14.52M |
| June 30, 2018 | 15.32M |
| March 31, 2018 | 14.32M |
| December 31, 2017 | 12.73M |
| September 30, 2017 | 12.84M |
| June 30, 2017 | 13.31M |
| March 31, 2017 | 12.52M |
| December 31, 2016 | 11.79M |
| September 30, 2016 | 11.42M |
| June 30, 2016 | 11.53M |
| March 31, 2016 | 10.59M |
| December 31, 2015 | 11.42M |
| September 30, 2015 | 10.52M |
| June 30, 2015 | 9.202M |
| March 31, 2015 | 9.672M |
| December 31, 2014 | 9.523M |
| September 30, 2014 | 8.688M |
| June 30, 2014 | 9.641M |
| March 31, 2014 | 8.78M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 36.32M |
| Baxter International, Inc. | 125.00M |
| DexCom, Inc. | 153.00M |
| Haemonetics Corp. | 16.21M |
| ICU Medical, Inc. | 22.70M |